-
12381por Goel, Ashish, Madhu, Kadiyala, Zachariah, Uday, Sajith, K.G., Ramachandran, Jeyamani, Ramakrishna, Banumathi, Gibikote, Sridhar, Jude, John, Chandy, George M., Elias, Elwyn, Eapen, C.E.“…After non-invasive testing, commonest causes of portal hypertension were cryptogenic chronic liver disease (35%), chronic liver disease due to alcohol (29%), hepatitis B (17%) or hepatitis C (9%). Of the 203 patients with cryptogenic chronic liver disease, 39 had liver biopsy - amongst the latter, idiopathic non cirrhotic intrahepatic portal hypertension (NCIPH) was seen in 16 patients (41%), while five patients had cirrhosis due to non alcoholic fatty liver disease. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12382“…We investigated the biological importance of this mechanism in human cells and found that hepatitis C virus (HCV) abrogated this mechanism. Interestingly, HCV NS3-4A proteases targeted the Riplet protein and abrogated endogenous RIG-I polyubiquitination and association with TRIM25 and TBK1, emphasizing the biological importance of this mechanism in human antiviral innate immunity. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12383por Nishida, Naoshi, Kudo, Masatoshi, Nishimura, Takafumi, Arizumi, Tadaaki, Takita, Masahiro, Kitai, Satoshi, Yada, Norihisa, Hagiwara, Satoru, Inoue, Tatsuo, Minami, Yasunori, Ueshima, Kazuomi, Sakurai, Toshiharu, Yokomichi, Naosuke, Nagasaka, Takeshi, Goel, Ajay“…Progression of hypomethylation during carcinogenesis was more prominent in hepatitis C virus (HCV)-negative cases, which was in contrast to our previous reports of significantly increased TSG methylation levels in HCV-positive tumors. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12384“…Subgroup analysis showed that IFN reduced the 2-, 3-, 4-, and 5-year recurrence rates of hepatitis C viral (HCV)-related HCC. The effect of IFN for on hepatitis B virus(HBV)-related HCC patients could not be determined because of isufficient data. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12385por Lai, G Y, Weinstein, S J, Albanes, D, Taylor, P R, McGlynn, K A, Virtamo, J, Sinha, R, Freedman, N D“…BACKGROUND: Coffee intake is associated with reduced risk of liver cancer and chronic liver disease as reported in previous studies, including prospective ones conducted in Asian populations where hepatitis B viruses (HBVs) and hepatitis C viruses (HCVs) are the dominant risk factors. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12386“…This study aims to estimate the prevalence levels of HIV, Hepatitis C (HCV), Tuberculosis (TB) and their co-infections and associated demographic and risk behaviours among MMT entrants. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12387por Zhao, Bin-Bin, Zheng, Su-Jun, Gong, Lu-Lu, Wang, Yu, Chen, Cai-Feng, Jin, Wen-Jing, Zhang, Ding, Yuan, Xiao-Hui, Guo, Jian, Duan, Zhong-Ping, He, You-Wen“…Although extensive studies have demonstrated the functional impairment of antigen-specific CD4(+) and CD8(+) T-cells during chronic hepatitis C virus (HCV) infection, the functional status of global CD4(+) and CD8(+) T-cells remains unclear. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12388por Guo, Xiaoyan, Yang, Guilin, Yuan, Jin, Ruan, Peng, Zhang, Mingxia, Chen, Xincun, Zhou, Boping“…Concurrent infection with hepatitis C virus (HCV) and hepatitis B virus (HBV) was not uncommon in China. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12389por Mizuno, Shugo, Muraki, Yuichi, Nakatani, Kaname, Tanemura, Akihiro, Kuriyama, Naohisa, Ohsawa, Ichiro, Azumi, Yoshinori, Kishiwada, Masashi, Usui, Masanobu, Sakurai, Hiroyuki, Tabata, Masami, Yamamoto, Norihiko, Yamada, Tomomi, Shiraki, Katsuya, Takei, Yoshiyuki, Nobori, Tsutomu, Okuda, Masahiro, Isaji, Shuji“…The mean ATP level of the IMK assay was significantly lower in the patients with infection including recurrence of hepatitis C (HCV) (n = 10) than in those without infection (n = 39): 185 versus 350 ng/mL (P < 0.001), while it was significantly higher in the patients with rejection (n = 4) than in those without rejection (n = 45): 663 versus 306 ng/mL (P < 0.001). …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12390por Montella, Maurizio, Malvezzi, Matteo, Grimaldi, Maria, Nocerino, Flavia, Frigeri, Ferdinando, Pinto, Antonio, Giudice, Aldo, Crispo, Anna“…BACKGROUND: In many regions of southern Italy, hepatitis C virus (HCV) infection represents a major health problem (with a prevalence rate between 6% and 13%). …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12391por Cha, Jung Hoon, Bae, Si Hyun, Kim, Hye Lim, Park, Na Ri, Choi, Eun Suk, Jung, Eun Sun, Choi, Jong Young, Yoon, Seung Kew“…PURPOSE: Recent studies have revealed that branched-chain amino acids (BCAA) reduce the development of hepatocellular carcinoma (HCC) in patients with obesity and hepatitis C virus infection by improving insulin resistance (IR). …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12392por Jones, Andrea A., Vila-Rodriguez, Fidel, Panenka, William J., Leonova, Olga, Strehlau, Verena, Lang, Donna J., Thornton, Allen E., Wong, Hubert, Barr, Alasdair M., Procyshyn, Ric M., Smith, Geoffrey N., Buchanan, Tari, Krajden, Mel, Krausz, Michael, Montaner, Julio S., MacEwan, G. William, Nutt, David J., Honer, William G.“…Adjusting for age and sex, every 1000-unit CHS increase was associated with greater mortality (odds ratio [OR] 1.47, 95% confidence interval [CI] 1.07–2.01, p = 0.02), and persistent hepatitis C infection (OR 1.29, 95% CI 1.02–1.67, p = 0.04). …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12393por Himoto, Takashi, Tani, Joji, Miyoshi, Hisaaki, Morishita, Asahiro, Yoneyama, Hirohito, Kurokohchi, Kazutaka, Inukai, Michio, Masugata, Hisashi, Goda, Fuminori, Senda, Shoichi, Haba, Reiji, Ueno, Masaki, Yamaoka, Genji, Masaki, Tsutomu“…BACKGROUND: CD36, a class B scavenger receptor, participates in the pathogenesis of metabolic dysregulation such as insulin resistance, hepatic steatosis, and atherosclerosis. Persistent hepatitis C virus (HCV) infection often evokes these metabolic abnormalities. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12394por Nakamura, Masato, Kanda, Tatsuo, Nakamoto, Shingo, Miyamura, Tatsuo, Jiang, Xia, Wu, Shuang, Yokosuka, Osamu“…BACKGROUND: Hepatitis C virus (HCV) infection is associated with the development of cirrhosis and hepatocellular carcinoma and is also related to fatty change of the liver. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12395por Kuznetsova, Tatiana, Tallo, Tatjana, Brjalin, Vadim, Reshetnjak, Irina, Salupere, Riina, Priimagi, Ljudmilla, Katargina, Olga, Smirnova, Maria, Jansons, Juris, Tefanova, Valentina“…BACKGROUND: A substantial proportion of hepatitis C virus (HCV)-1b infected patients do not response to pegylated interferon-α plus ribavirin (PegIFNα/RBV) combination therapy that was partially associated with mutations in the non-structural 5A (NS5A) protein. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12396por Kotaki, Tomohiro, Khairunisa, Siti Qamariyah, Sukartiningrum, Septhia Dwi, Arfijanto, M. Vitanata, Utsumi, Takako, Normalina, Irine, Handajani, Retno, Widiyanti, Prihartini, Rusli, Musofa, Rahayu, Retno Pudji, Lusida, Maria Inge, Hayashi, Yoshitake, Nasronudin, Kameoka, Masanori“…In addition, the subtype of HIV type 1 (HIV-1) and the prevalence of other blood-borne viruses, hepatitis B virus (HBV), hepatitis C virus (HCV) and GB virus C (GBV-C), were studied. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12397por Rongey, Catherine, Shen, Hui, Hamilton, Nathan, Backus, Lisa I., Asch, Steve M., Knight, Sara“…As effective drug treatment for hepatitis C (HCV) becomes increasingly available, the extent to which rural patients needing HCV specialists face access or quality deficits is unknown. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12398“…BACKGROUND: Hepatitis C infection (HCV) among individuals aged 15–24 years has increased in Massachusetts, likely due to injection drug use. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12399por Meijerink, Hinta, Wisaksana, Rudi, Iskandar, Shelly, den Heijer, Martin, van der Ven, Andre J A M, Alisjahbana, Bachti, van Crevel, Reinout“…We examined the association between IDU and CD4 cell decline using a linear mixed model, with adjustment for possible confounders such as HIV viral load and hepatitis C antibodies. RESULTS: Among 284 HIV-positive ART naïve patients, the majority were male (56%) with a history of IDU (79% among men). …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12400por Ohsawa, Masaki, Kato, Karen, Tanno, Kozo, Itai, Kazuyoshi, Fujishima, Yosuke, Okayama, Akira, Turin, Tanvir Chowdhury, Onoda, Toshiyuki, Suzuki, Kazuyuki, Nakamura, Motoyuki, Kawamura, Kazuko, Akiba, Takashi, Sakata, Kiyomi, Fujioka, Tomoaki“…BACKGROUND: It is not known whether chronic or past hepatitis C virus (HCV) infection contributes to the high mortality rate in hemodialysis patients. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto